Krystal Biotech, Inc. KRYS
298.55 USD +0.65 (+0.22%)
Regular-session close
318.12 +19.57 +6.55%
Pre-market · Nov 18, 5:46 AM ET
295.06 Day range 299.80
203.18 52-week range 382.54
- YTD
- +21.10%
- 1 year
- +45.82%
KRYS revenue history
Revenue is income from the company’s ordinary business activities.
389,130,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 389,130,000 | 98,615,000 | 33.94% |
| FY 2024 | 2024-12-31 | 290,515,000 | 239,816,000 | 473.02% |
| FY 2023 | 2023-12-31 | 50,699,000 | 50,699,000 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | 0 | Not meaningful |
| FY 2021 | 2021-12-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-05T06:02:01.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
